New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 29, 2014
06:43 EDTHZNPHorizon Pharma downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray downgraded Horizon Pharma to Neutral citing uncertainty following decisions by CVS Caremark and Express Scripts to exclude Duexis and Vimovo from their formularies effective 1/1/15. Piper lowered its price target for shares to $9 from $22.
News For HZNP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for HZNP

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use